Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
69°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seres Therapeutics Inc
(NQ:
MCRB
)
0.7494
-0.3606 (-32.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seres Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Today 13:38 EDT
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Today 12:31 EDT
Via
Benzinga
Seres Therapeutics's Earnings: A Preview
March 04, 2024
Via
Benzinga
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q1 2024
Today 11:54 EDT
MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Nasdaq Down Over 50 Points; Uber Posts Q1 Loss
Today 10:02 EDT
Via
Benzinga
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Today 7:00 EDT
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
May 06, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
April 09, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 19, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
March 06, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Gold Price Alert: Gold Spot Prices Just Hit a Record High Today
March 05, 2024
Investors in gold are excited on Tuesday as the spot price of the precious metal hit a recent high of $2,113.28 per ounce during a rally.
Via
InvestorPlace
MCRB Stock Earnings: Seres Therapeutics Beats EPS for Q4 2023
March 05, 2024
MCRB stock results show that Seres Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
March 05, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
February 28, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
February 27, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For March 5, 2024
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
February 26, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Why Is Microbiome-Based Seres Therapeutics Stock Trading Higher Today?
January 09, 2024
Seres Therapeutics Inc (NASDAQ: MCRB) received FDA Fast Track Designation for SER-155, an investigational oral, cultivated microbiome therapeutic designed to prevent GI-associated bacterial infections...
Via
Benzinga
Exposures
Product Safety
Dow Tumbles Over 200 Points; US Trade Gap Narrows In November
January 09, 2024
U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.63% to 37,445.51 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 09, 2024
Via
Benzinga
Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
January 09, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
December 07, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
November 28, 2023
From
Seres Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
November 20, 2023
Via
Benzinga
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.
Via
Benzinga
Nasdaq Gains 1%; US Adds 150,000 Jobs In October
November 03, 2023
U.S. stocks traded higher this morning, following the release of jobs report for October. Following the market opening Friday, the Dow traded up 0.50% to 34,009.36 while the NASDAQ rose 1% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.